Physician profile
Michael H Manning
NPI 1093733271
$7,619.89
in general payments reported to CMS, 2019-2025
29 companies · $2,210 in 2025
The $2,210 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $198 · 2021: $1,101 · 2022: $1,062 · 2023: $844 · 2024: $1,403 · 2025: $2,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,383 · Honoraria: $38.86 · Gift: $36.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,382.65 |
| Honoraria | $38.86 |
| Gift | $36.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,526.50 | 2019-2025 | Clareon, Centurion, Hydrus Microstent |
| Abbvie INC. | $945.12 | 2022-2025 | |
| Glaukos Corporation | $703.67 | 2019-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Harrow Eye, LLC | $687.53 | 2024-2025 | Triesence, Iheezo |
| Carl Zeiss Meditec USA, INC. | $374.07 | 2021-2025 | Visumax |
| Johnson & Johnson Surgical Vision, INC. | $357.19 | 2019-2025 | Catalys System, Tecnis Iol |
| Bausch & Lomb Americas INC. | $342.37 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Ocular Therapeutix, INC. | $261.95 | 2019-2023 | Dextenza |
| Nova Eye, INC. | $258.92 | 2024-2025 | |
| New World Medical,INC. | $254.19 | 2023 | |
| Horizon Therapeutics Plc | $242.74 | 2022-2023 | Tepezza |
| Rxsight INC | $218.49 | 2024-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Beaver-Visitec International, INC. | $207.09 | 2020-2022 | |
| Allergan, INC. | $171.17 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.20 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Staar Surgical Company | $159.17 | 2019 | |
| Sight Sciences, INC. | $137.99 | 2022-2025 | Sion Surgical Instrument, Omni Surgical System |
| Regeneron Healthcare Solutions, INC. | $125.01 | 2021 | |
| Kala Pharmaceuticals, INC. | $124.99 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $120.83 | 2019 | |
| Carl Zeiss Meditec, INC. | $60.37 | 2021 | |
| Dompe US, INC. | $29.71 | 2024 | Oxervate |
| Teva Pharmaceuticals USA, INC. | $25.14 | 2022 | |
| Quidel Corporation | $24.34 | 2019 | |
| Shire North American Group INC | $22.07 | 2019 | |
| Oyster Point Pharma, INC. | $21.74 | 2022 | |
| Biotissue Holdings INC. | $20.97 | 2025 | |
| Amgen INC. | $19.70 | 2019 | |
| Iridex Corporation | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.